238 related articles for article (PubMed ID: 19177143)
1. Wnt5A activates the calpain-mediated cleavage of filamin A.
O'Connell MP; Fiori JL; Baugher KM; Indig FE; French AD; Camilli TC; Frank BP; Earley R; Hoek KS; Hasskamp JH; Elias EG; Taub DD; Bernier M; Weeraratna AT
J Invest Dermatol; 2009 Jul; 129(7):1782-9. PubMed ID: 19177143
[TBL] [Abstract][Full Text] [Related]
2. Loss of Klotho during melanoma progression leads to increased filamin cleavage, increased Wnt5A expression, and enhanced melanoma cell motility.
Camilli TC; Xu M; O'Connell MP; Chien B; Frank BP; Subaran S; Indig FE; Morin PJ; Hewitt SM; Weeraratna AT
Pigment Cell Melanoma Res; 2011 Feb; 24(1):175-86. PubMed ID: 20955350
[TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A.
Nomachi A; Nishita M; Inaba D; Enomoto M; Hamasaki M; Minami Y
J Biol Chem; 2008 Oct; 283(41):27973-27981. PubMed ID: 18667433
[TBL] [Abstract][Full Text] [Related]
4. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
5. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
6. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
7. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration.
Nishita M; Yoo SK; Nomachi A; Kani S; Sougawa N; Ohta Y; Takada S; Kikuchi A; Minami Y
J Cell Biol; 2006 Nov; 175(4):555-62. PubMed ID: 17101698
[TBL] [Abstract][Full Text] [Related]
8. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
9. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
10. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
11. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase.
Liu Y; Rubin B; Bodine PV; Billiard J
J Cell Biochem; 2008 Oct; 105(2):497-502. PubMed ID: 18615587
[TBL] [Abstract][Full Text] [Related]
13. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression.
Yamagata K; Li X; Ikegaki S; Oneyama C; Okada M; Nishita M; Minami Y
J Biol Chem; 2012 Jan; 287(2):1588-99. PubMed ID: 22128168
[TBL] [Abstract][Full Text] [Related]
14. Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.
Schwartz AL; Malgor R; Dickerson E; Weeraratna AT; Slominski A; Wortsman J; Harii N; Kohn AD; Moon RT; Schwartz FL; Goetz DJ; Kohn LD; McCall KD
Clin Cancer Res; 2009 Jun; 15(12):4114-22. PubMed ID: 19470740
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer.
Lu C; Wang X; Zhu H; Feng J; Ni S; Huang J
Oncotarget; 2015 Sep; 6(28):24912-21. PubMed ID: 26305508
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycan modulation of Wnt5A signal transduction in metastatic melanoma cells.
O'Connell MP; Fiori JL; Kershner EK; Frank BP; Indig FE; Taub DD; Hoek KS; Weeraratna AT
J Biol Chem; 2009 Oct; 284(42):28704-12. PubMed ID: 19696445
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
18. Calpain 1-gamma filamin interaction in muscle cells: a possible in situ regulation by PKC-alpha.
Raynaud F; Jond-Necand C; Marcilhac A; Fürst D; Benyamin Y
Int J Biochem Cell Biol; 2006 Mar; 38(3):404-13. PubMed ID: 16297652
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas.
Li L; Ying J; Tong X; Zhong L; Su X; Xiang T; Shu X; Rong R; Xiong L; Li H; Chan AT; Ambinder RF; Guo Y; Tao Q
Cell Mol Life Sci; 2014 Jun; 71(11):2179-92. PubMed ID: 24158497
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]